Submitted Successfully!
Thank you for your contribution! You can also upload a video entry or images related to this topic.
Ver. Summary Created by Modification Content Size Created at Operation
1 -- 2137 2023-07-11 09:31:59 |
2 layout Meta information modification 2137 2023-07-11 09:54:09 |

Video Upload Options

Do you have a full video?

Confirm

Are you sure to Delete?
Cite
If you have any further questions, please contact Encyclopedia Editorial Office.
Abubakar, B.; Usman, D.; Sanusi, K.O.; Azmi, N.H.; Imam, M.U. The Role of Epigenetics in Type 2 Diabetes. Encyclopedia. Available online: https://encyclopedia.pub/entry/46628 (accessed on 11 December 2023).
Abubakar B, Usman D, Sanusi KO, Azmi NH, Imam MU. The Role of Epigenetics in Type 2 Diabetes. Encyclopedia. Available at: https://encyclopedia.pub/entry/46628. Accessed December 11, 2023.
Abubakar, Bilyaminu, Dawoud Usman, Kamaldeen Olalekan Sanusi, Nur Hanisah Azmi, Mustapha Umar Imam. "The Role of Epigenetics in Type 2 Diabetes" Encyclopedia, https://encyclopedia.pub/entry/46628 (accessed December 11, 2023).
Abubakar, B., Usman, D., Sanusi, K.O., Azmi, N.H., & Imam, M.U.(2023, July 11). The Role of Epigenetics in Type 2 Diabetes. In Encyclopedia. https://encyclopedia.pub/entry/46628
Abubakar, Bilyaminu, et al. "The Role of Epigenetics in Type 2 Diabetes." Encyclopedia. Web. 11 July, 2023.
The Role of Epigenetics in Type 2 Diabetes
Edit

Type 2 diabetes (T2D) is characterised by high levels of blood glucose resulting from a combination of factors, including insulin resistance, a decrease in insulin secretion, and an increase in glucose production by the liver. Epigenetic changes have been shown to influence these factors through changes in changes in gene expression patterns.

diabetes epigenetic inheritance functional foods

1. Introduction

1.1. Background on Type 2 Diabetes and Its Treatment Approaches

Diabetes is the seventh-leading cause of global mortality, and has surpassed pandemic proportions. From less than 1 million deaths in the year 2000, the disease was responsible for almost 7 million deaths in 2021 [1]. Type 2 diabetes (T2D) is specifically characterised by high levels of glucose in the blood resulting from a combination of factors, including insulin resistance, a decrease in insulin secretion, and an increase in glucose production by the liver [2]. T2D causes significant morbidity and mortality worldwide, and is associated with a number of serious health complications, such as cardiovascular disease, kidney disease, and blindness [3][4].
Owing to the fact that a high consumption of unhealthy diets, and sedentary lifestyles have been greatly implicated, the current treatment approaches for T2D include lifestyle modifications (e.g., healthy diet and physical activity), oral medications, and insulin therapy [5][6]. Lifestyle modifications are considered the cornerstone of T2D management, and are often the first line of treatment for individuals with prediabetes or newly diagnosed T2D. In addition to lifestyle changes, oral medications, such as metformin, sulfonylureas, and dipeptidyl peptidase-4 (DPP-4) inhibitors are commonly used to improve insulin sensitivity, increase insulin secretion, and decrease glucose production [7][8]. For individuals who require more intensive therapy, insulin therapy may be recommended.
While these traditional approaches have been effective in managing T2D, they have limitations, and may not be effective for all individuals. As such, there is a growing interest in developing alternative strategies for preventing and managing T2D, including the use of functional foods with demonstrated preventive epigenetic effects [9].
Even though the disease has no known cure, a combination of lifestyle modification and drug therapy in diagnosed individuals has shown great success in reducing mortality and increasing quality of life. More important, as advocated by the World Health Organisation, is the preventive narrative in reducing the global burden of the disease. Diet has been a cornerstone in the prevention of diabetes since the era of classical Greece, as declared in the tenet “Let food be thy medicine and medicine be thy food”, by Hippocrates.

1.2. Dietary Lifestyle as a Risk Factor for Type 2 Diabetes

The risk of developing type 2 diabetes has been largely linked to either environmental, lifestyle, or genetic factors [10]. Concrete data have linked lifestyle factors such as diet [11], heavy smoking [12], opioid use [13], physical inactivity (sedentarism), obesity [14][15], and alcoholism [16][17] to type 2 diabetes. Individual diets (food) and some dietary combinations have the potential to differentially impact the risk of developing type 2 diabetes [18][19]. Numerous studies have shown that the type of food people consume could be associated with the development of diabetes. In a cross-sectional study, Shu et al. demonstrated an association between consuming a Western diet, and the risk of type 2 diabetes mellitus among middle-aged Chinese adults [20]. Moreover, several cohort and preclinical studies have highlighted diet as a contributory factor in the predisposition to type 2 diabetes mellitus [11][21][22][23]. A high-fibre diet, low glycaemic index diet, and high amylose diet have been associated with a lesser predisposition to type 2 diabetes, when compared to their counterparts [24][25][26]. Nuts have also been shown to be beneficial in preclusion to type 2 diabetes. On the other hand, refined grains and sugar-sweetened beverages tend to promote a predisposition to type 2 diabetes [27]. For instance, clinical trials of short- and medium-term durations on postprandial glucose excursion in normal patients, insulin sensitivity in obese patients, and glucose handling in diabetic patients confirmed the superiority of a whole-grain diet over refined grains in maintaining a near-euglycemic state [28]. Studies have also shown that people who consume fermented dairy products are less likely to develop type 2 diabetes than those who consume non-fermented ones [29][30].

1.3. The Concept of Epigenetics, and Its Role in Chronic Diseases

Epigenetics is the study of changes in gene function that occur without a change in the underlying DNA sequence [31]. These changes are caused by modifications to DNA and its associated proteins, such as histones, which play a crucial role in regulating gene expression. There are several different types of epigenetic modifications, including DNA methylation, histone modification, and non-coding RNA-mediated regulation, all of which can have a significant impact on gene expression [32]. Epigenetic changes can occur in response to a variety of environmental and lifestyle factors, such as diet, physical activity, and exposure to toxins. These changes can be transmitted from one generation to the next, and may play a key role in the development and progression of chronic diseases, including T2D [33].
Studies have demonstrated that epigenetic changes can lead to alterations in the expression of genes involved in glucose metabolism, insulin secretion, and inflammation, which are all important factors in the development and progression of T2D [34]. Additionally, epigenetic changes can increase the risk of T2D by altering the expression of genes involved in fat metabolism, which can lead to obesity and insulin resistance [35]. Epigenome-wide association studies have substantially linked DNA methylation to diabetes [35]. Using human pancreatic islets, Daneshpajooh et al. also demonstrated that diabetes and impaired insulin secretion could result from epigenetic modifications that alter gene expression [36]. In addition, epidemiological findings in offspring born to Dutch Hunger Winter mothers during World War II have provided some evidence of the predisposition to diabetes due to intra-uterine perturbations [37]. On the other hand, several pieces of evidence also highlight the mechanistic role of epigenetics in the dietary mitigation of type 2 diabetes. For instance, Li et al. show that a diet high in folates reduces blood glucose levels and improves insulin sensitivity, by altering the DNA methylation patterns in the adipose tissues of genes associated with type 2 diabetes [38]. The role of epigenetics in chronic diseases such as T2D highlights the importance of environmental and lifestyle factors, such as diet, in disease prevention and management.

2. The Role of Epigenetics in T2D

2.1. Overview of Epigenetic Changes Associated with T2D

T2D is associated with epigenetic changes that can impact the expression of genes involved in glucose metabolism, insulin signaling, and inflammation. These epigenetic changes include the following:
i. DNA methylation: DNA methylation is a chemical modification that involves the addition of a methyl group to the DNA molecule. Methylated DNA in mammals is usually in the form of 5-methylcytosine. In lower organisms (Drosophila melanogaster, fungi, and bacteria), the majority of the methylated DNA is in the form of N6-methyladenine [39]. While N6-methyladenine has been associated with over-expression, 5-methylcytosine has been linked with gene repression [40][41]. In T2D, DNA methylation changes have been observed in genes involved in insulin secretion and glucose metabolism, leading to alterations in their expression and function [42]. Maternal high-fat diet consumption in mice during gestation and lactation has been demonstrated to cause insulin resistance and glucose intolerance in their F1 offspring, through the promotion of Irs2 DNA methylation, and a decrease in Map2k DNA methylation [43]. DNA methylation has been hypothesised to act by disrupting the binding of transcription factors to recognition elements (containing a CG nucleotide), leading to the silencing of gene expression [44]. These aberrations in DNA methylation (whether hypo- or hyper-methylations) are oftentimes secondary to DNA methyltransferases gene (DNMT1, DNMT3A, and DNMT3B) dysregulation/mutations.
ii. Histone modification: Histones are proteins that interact with DNA to help package it into a compact structure. Histone modifications include the phosphorylation, methylation, acetylation, and ubiquitination of histone molecules. This leads to conformational changes that remodel chromatin, thereby altering the activity and interactions of transcription factors, nuclear proteins, and histone molecules; this, in turn, affects gene transcription and its sequelae [45]. In T2D, changes in histone modification have been observed in genes involved in insulin sensitivity, glucose metabolism, and inflammation [46].
iii. Non-coding RNA-mediated regulation: Non-coding RNAs, such as microRNAs, are short RNA molecules that do not encode for proteins, but play a crucial role in regulating gene expression. For instance, the parental intake of five functional food oils has been shown to modulate miRNA expression in both the parent and offspring [47]. In addition, functional foods have also been shown to modulate the expression of lncRNA in parents and offspring [38][48][49][50]. Essentially, in T2D, changes in the expression of non-coding RNAs have been observed in genes involved in insulin secretion and glucose metabolism, leading to alterations in their function [51][52].
These epigenetic changes associated with T2D can also interact with other factors, such as obesity and physical inactivity, which are known to increase the risk of T2D [35]. The complex interplay between these factors highlights the importance of a holistic approach to the prevention and management of T2D, which takes into account both the genetic and environmental factors.
Furthermore, epigenetic changes in genes involved in insulin secretion and sensitivity, glucose metabolism, inflammation, and adipocyte differentiation and function can have a profound impact on the development of type 2 diabetes (T2D). Insulin secretion and sensitivity can be decreased due to these epigenetic changes, leading to insulin resistance, which is a defining characteristic of T2D. Additionally, alterations in glucose metabolism can result in an increase in glucose production by the liver, and elevated blood-glucose levels, due to changes in glucose uptake, utilisation, and storage in peripheral tissues. Inflammation is also impacted by these epigenetic changes, resulting in a persistent state of low-grade inflammation that is associated with the progression of T2D. Moreover, changes in the differentiation and function of adipocytes can lead to altered lipid storage and an increased risk of obesity and insulin resistance. These various changes accumulate over time, resulting in a progressive decline in glucose metabolism and insulin sensitivity, which can increase the likelihood of developing T2D and its associated health complications.

2.2. Epigenetic Inheritance of T2D

Based on the sustainability of a conferred metabolic disease along subsequent generations of offspring, an epigenetic transfer may be termed transgenerational, intergenerational or multigenerational [53]. Such epigenetic change(s) could be important therapeutic target(s) for reducing diabetes, because of the typical epigenetic signature of being modifiable and reversible. Numerous clinical observations and in vivo laboratory experiments involving animals have proved beyond conjecture that there is a generational link of type 2 diabetes between parents and their subsequent descendants. Compelling animal studies involving embryo transfer experiments [54], and discordant human siblings born to parent before and after the development of maternal diabetes [55] have given credence to the association between gestational diabetes and the development of later-life type 2 diabetes. Later generational phenotypic expressions (e.g., type 2 diabetes) consequent on “developmental programming” due to early-life environmental insults, especially the over- and under-nutrition of specific nutrients, have demonstrated the risk of a generational diabetic link between offspring and their parents [56][57][58]. Crudo et al. demonstrated a transgenerational association between late-gestation glucocorticoid intervention in F1 pregnant guinea pigs, and global DNA methylation and the expression of crucial metabolic genes in subsequent generations of offspring [59]. In an earlier study, maternal under-nutrition had been associated with transgenerational increased neonatal adiposity in the offspring of exposed women [60]. Furthermore, using a mouse model, Pavlinkova and colleagues have demonstrated the association between paternal diabetes and sperm quality, and expression patterns in the offspring of later generations [57]. With the foregoing observations, and many more reports in the literature, it is almost impossible to rule out the transmission of type 2 diabetes from parents to their subsequent generational offspring.
Accordingly, the underlying mechanisms responsible for the transmission of type 2 diabetes have been explored since the early 1990s. Diets have been shown to programme type 2 diabetes, by altering the structural and functional metabolic systems in adipose tissues, muscles, and the pancreas and liver [61][62][63]. Epigenetics have evolved as the underlying molecular mechanisms through which these dietary disturbances during intra-uterine life are registered and “reminisced” during later generations as metabolic dysfunctions such as type 2 diabetes. These metabolic dysfunctions occur through upstream modifications in epigenetic signatures which influence gene expression without tampering with the DNA sequence. For example, studies have shown that diet influences the expression of intestinal fatty acid binding protein (IFABP) mRNA, which will in turn affect all downstream processes affected by its protein [64]. IFABP is known to be an expressed product of the FABP2 gene, which is responsible for a myriad of fatty acid trafficking processes across several metabolic pathways. This report indicates that diet can modify the epigenetic memory of specific genes, which in turn affects the expression of proteins responsible for the handling of specific metabolic pathways involving the homeostasis of blood glucose and body weight. This, in the long run, impacts the development of heritable type 2 diabetes mellitus.
Therefore, understanding the specifics of these changes is crucial for the development of new strategies for preventing and managing the disease, including the use of functional foods with preventive epigenetic effects.

References

  1. World Health Organization. WHO—The Top 10 Causes of Death. 24 Maggio; World Health Organization: Geneva, Switzerland, 2018; pp. 1–7.
  2. Hameed, I.; Masoodi, S.R.; Mir, S.A.; Nabi, M.; Ghazanfar, K.; Ganai, B.A. Type 2 Diabetes Mellitus: From a Metabolic Disorder to an Inflammatory Condition. World J. Diabetes 2015, 6, 598.
  3. Deshpande, A.D.; Harris-Hayes, M.; Schootman, M. Epidemiology of Diabetes and Diabetes-Related Complications. Phys. Ther. 2008, 88, 1254–1264.
  4. Petrie, J.R.; Guzik, T.J.; Touyz, R.M. Diabetes, Hypertension, and Cardiovascular Disease: Clinical Insights and Vascular Mechanisms. Can. J. Cardiol. 2018, 34, 575–584.
  5. Magkos, F.; Yannakoulia, M.; Chan, J.L.; Mantzoros, C.S. Management of the Metabolic Syndrome and Type 2 Diabetes through Lifestyle Modification. Annu. Rev. Nutr. 2009, 29, 223–256.
  6. Asif, M. The Prevention and Control the Type-2 Diabetes by Changing Lifestyle and Dietary Pattern. J. Educ. Health Promot. 2014, 3, 1.
  7. Chaudhury, A.; Duvoor, C.; Reddy Dendi, V.S.; Kraleti, S.; Chada, A.; Ravilla, R.; Marco, A.; Shekhawat, N.S.; Montales, M.T.; Kuriakose, K.; et al. Clinical Review of Antidiabetic Drugs: Implications for Type 2 Diabetes Mellitus Management. Front. Endocrinol. 2017, 8, 6.
  8. Sola, D.; Rossi, L.; Schianca, G.P.C.; Maffioli, P.; Bigliocca, M.; Mella, R.; Corlianò, F.; Paolo Fra, G.; Bartoli, E.; Derosa, G. Sulfonylureas and Their Use in Clinical Practice. Arch. Med. Sci. 2015, 11, 840–848.
  9. Alkhatib, A.; Tsang, C.; Tiss, A.; Bahorun, T.; Arefanian, H.; Barake, R.; Khadir, A.; Tuomilehto, J. Functional Foods and Lifestyle Approaches for Diabetes Prevention and Management. Nutrients 2017, 9, 1310.
  10. Kolb, H.; Martin, S. Environmental/Lifestyle Factors in the Pathogenesis and Prevention of Type 2 Diabetes. BMC Med. 2017, 15, 131.
  11. Abubakar, B.; Zawawi, N.; Omar, A.R.; Ismail, M. Predisposition to Insulin Resistance and Obesity due to Staple Consumption of Rice: Amylose Content versus Germination Status. PLoS ONE 2017, 12, e0181309.
  12. Chang, S.A. Smoking and Type 2 Diabetes Mellitus. Diabetes Metab. J. 2012, 36, 399–403.
  13. Toorie, A.M.; Vassoler, F.M.; Qu, F.; Schonhoff, C.M.; Bradburn, S.; Murgatroyd, C.A.; Slonim, D.K.; Byrnes, E.M. A History of Opioid Exposure in Females Increases the Risk of Metabolic Disorders in Their Future Male Offspring. Addict. Biol. 2021, 26, e12856.
  14. Uusitupa, M. Lifestyles Matter in the Prevention of Type 2 Diabetes. Diabetes Care 2002, 25, 1650–1651.
  15. Silva, D.A.S.; Naghavi, M.; Duncan, B.B.; Schmidt, M.I.; de Souza, M.d.F.M.; Malta, D.C. Physical Inactivity as Risk Factor for Mortality by Diabetes Mellitus in Brazil in 1990, 2006, and 2016. Diabetol. Metab. Syndr. 2019, 11, 23.
  16. Al-Yasari, A.; Jabbar, S.; Cabrera, M.A.; Rousseau, B.; Sarkar, D.K. Preconception Alcohol Exposure Increases the Susceptibility to Diabetes in the Offspring. Endocrinology 2021, 162, bqaa188.
  17. Holst, C.; Becker, U.; Jørgensen, M.E.; Grønbæk, M.; Tolstrup, J.S. Alcohol Drinking Patterns and Risk of Diabetes: A Cohort Study of 70,551 Men and Women from the General Danish Population. Diabetologia 2017, 60, 1941–1950.
  18. Da Porto, A.; Cavarape, A.; Colussi, G.; Casarsa, V.; Catena, C.; Sechi, L.A. Polyphenols Rich Diets and Risk of Type 2 Diabetes. Nutrients 2021, 13, 1445.
  19. Tertsunen, H.M.; Hantunen, S.; Tuomainen, T.P.; Virtanen, J.K. Adherence to a Healthy Nordic Diet and Risk of Type 2 Diabetes among Men: The Kuopio Ischaemic Heart Disease Risk Factor Study. Eur. J. Nutr. 2021, 60, 3927–3934.
  20. Shu, L.; Shen, X.M.; Li, C.; Zhang, X.Y.; Zheng, P.F. Dietary Patterns Are Associated with Type 2 Diabetes Mellitus among Middle-Aged Adults in Zhejiang Province, China. Nutr. J. 2017, 16, 81.
  21. Imam, M.U.; Ishaka, A.; Ooi, D.J.; Zamri, N.D.M.; Sarega, N.; Ismail, M.; Esa, N.M. Germinated Brown Rice Regulates Hepatic Cholesterol Metabolism and Cardiovascular Disease Risk in Hypercholesterolaemic Rats. J. Funct. Foods 2014, 8, 193–203.
  22. Stegemann, R.; Buchner, D.A. Transgenerational Inheritance of Metabolic Disease. Semin. Cell Dev. Biol. 2015, 43, 131–140.
  23. Steyn, N.P.; Mann, J.; Bennett, P.H.; Temple, N.; Zimmet, P.; Tuomilehto, J.; Lindström, J.; Louheranta, A. Diet, Nutrition and the Prevention of Type 2 Diabetes. Public Health Nutr. 2004, 7, 147–165.
  24. Abubakar, B.; Yakasai, H.M.; Zawawi, N.; Ismail, M. Compositional Analyses of White, Brown and Germinated Forms of Popular Malaysian Rice to Offer Insight into the Growing Diet-Related Diseases. J. Food Drug Anal. 2018, 26, 706–715.
  25. Kusuyama, J.; Makarewicz, N.S.; Albertson, B.G.; Alves-Wagner, A.B.; Conlin, R.H.; Prince, N.B.; Alves, C.R.R.; Ramachandran, K.; Kozuka, C.; Yang, X.; et al. Maternal Exercise-Induced SOD3 Reverses the Deleterious Effects of Maternal High-Fat Diet on Offspring Metabolism Through Stabilization of H3K4me3 and Protection Against WDR82 Carbonylation. Diabetes 2022, 71, 1170–1181.
  26. Liu, S.; Manson, J.E.; Stampfer, M.J.; Hu, F.B.; Giovannucci, E.; Colditz, G.A.; Hennekens, C.H.; Willett, W.C. A Prospective Study of Whole-Grain Intake and Risk of Type 2 Diabetes Mellitus in US Women. Am. J. Public Health 2000, 90, 1409–1415.
  27. Maki, K.C.; Phillips, A.K. Dietary Substitutions for Refined Carbohydrate That Show Promise for Reducing Risk of Type 2 Diabetes in Men and Women. J. Nutr. 2015, 145, 159s–163s.
  28. Samra, R.A.; Anderson, G.H. Insoluble Cereal Fiber Reduces Appetite and Short-Term Food Intake and Glycemic Response to Food Consumed 75 Min Later by Healthy Men. Am. J. Clin. Nutr. 2007, 86, 972–979.
  29. Arihara, K. Functional Foods. Encycl. Meat Sci. 2014, 2, 32–36.
  30. Schwingshackl, L.; Hoffmann, G.; Lampousi, A.M.; Knüppel, S.; Iqbal, K.; Schwedhelm, C.; Bechthold, A.; Schlesinger, S.; Boeing, H. Food Groups and Risk of Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Prospective Studies. Eur. J. Epidemiol. 2017, 32, 363–375.
  31. Wu, C.; Morris, J.R. Genes, Genetics, and Epigenetics: A Correspondence. Science 2001, 293, 1103–1105.
  32. Gibney, E.R.; Nolan, C.M. Epigenetics and Gene Expression. Heredity (Edinb) 2010, 105, 4–13.
  33. Sanusi, K.O.; Uthman, Y.A.; Ooi, D.J.; Ismail, M.; Imam, M.U. Lifestyle and Preventive Medical Epigenetics. Med. Epigenetics 2021, 29, 33–50.
  34. Ahmed, S.A.H.; Ansari, S.A.; Mensah-Brown, E.P.K.; Emerald, B.S. The Role of DNA Methylation in the Pathogenesis of Type 2 Diabetes Mellitus. Clin. Epigenetics 2020, 12, 104.
  35. Ling, C.; Rönn, T. Epigenetics in Human Obesity and Type 2 Diabetes. Cell Metab. 2019, 29, 1028–1044.
  36. Daneshpajooh, M.; Bacos, K.; Bysani, M.; Bagge, A.; Ottosson Laakso, E.; Vikman, P.; Eliasson, L.; Mulder, H.; Ling, C. HDAC7 Is Overexpressed in Human Diabetic Islets and Impairs Insulin Secretion in Rat Islets and Clonal Beta Cells. Diabetologia 2017, 60, 116–125.
  37. Tobi, E.W.; Slieker, R.C.; Luijk, R.; Dekkers, K.F.; Stein, A.D.; Xu, K.M.; Slagboom, P.E.; van Zwet, E.W.; Lumey, L.H.; Heijmans, B.T. DNA Methylation as a Mediator of the Association between Prenatal Adversity and Risk Factors for Metabolic Disease in Adulthood. Sci. Adv. 2018, 4, eaao4364.
  38. Li, J.; Li, K.; Gao, J.; Guo, X.; Lu, M.; Li, Z.; Li, D. Maternal Exposure to an N-3 Polyunsaturated Fatty Acid Diet Decreases Mammary Cancer Risk of Female Offspring in Adulthood. Food Funct. 2018, 9, 5768–5777.
  39. Sun, Q.; Huang, S.; Wang, X.; Zhu, Y.; Chen, Z.; Chen, D. N6-Methyladenine Functions as a Potential Epigenetic Mark in Eukaryotes. Bioessays 2015, 37, 1155–1162.
  40. Deaton, A.M.; Bird, A. CpG Islands and the Regulation of Transcription. Genes Dev. 2011, 25, 1010–1022.
  41. Zhang, G.; Huang, H.; Liu, D.; Cheng, Y.; Liu, X.; Zhang, W.; Yin, R.; Zhang, D.; Zhang, P.; Liu, J.; et al. N6-Methyladenine DNA Modification in Drosophila. Cell 2015, 161, 893–906.
  42. Bansal, A.; Pinney, S.E. DNA Methylation and Its Role in the Pathogenesis of Diabetes. Pediatr. Diabetes 2017, 18, 167–177.
  43. Zhang, Q.; Xiao, X.; Zheng, J.; Li, M.; Yu, M.; Ping, F.; Wang, T.; Wang, X. A Maternal High-Fat Diet Induces DNA Methylation Changes That Contribute to Glucose Intolerance in Offspring. Front. Endocrinol. 2019, 10, 871.
  44. Blake, G.E.T.; Watson, E.D. Unravelling the Complex Mechanisms of Transgenerational Epigenetic Inheritance. Curr. Opin. Chem. Biol. 2016, 33, 101–107.
  45. Alaskhar Alhamwe, B.; Khalaila, R.; Wolf, J.; von Bülow, V.; Harb, H.; Alhamdan, F.; Hii, C.S.; Prescott, S.L.; Ferrante, A.; Renz, H.; et al. Histone Modifications and Their Role in Epigenetics of Atopy and Allergic Diseases. Allergy Asthma Clin. Immunol. 2018, 14, 39.
  46. Yang, Y.; Luan, Y.; Feng, Q.; Chen, X.; Qin, B.; Ren, K.D.; Luan, Y. Epigenetics and Beyond: Targeting Histone Methylation to Treat Type 2 Diabetes Mellitus. Front. Pharmacol. 2022, 12, 4068.
  47. Casas-Agustench, P.; Fernandes, F.S.; Tavares do Carmo, M.G.; Visioli, F.; Herrera, E.; Dávalos, A. Consumption of Distinct Dietary Lipids during Early Pregnancy Differentially Modulates the Expression of microRNAs in Mothers and Offspring. PLoS ONE 2015, 10, e0117858.
  48. Mantilla-Escalante, D.C.; López de las Hazas, M.-C.; Crespo, M.C.; Martín-Hernández, R.; Tomé-Carneiro, J.; del Pozo-Acebo, L.; Salas-Salvadó, J.; Bulló, M.; Dávalos, A. Mediterranean Diet Enriched in Extra-Virgin Olive Oil or Nuts Modulates Circulating Exosomal Non-Coding RNAs. Eur. J. Nutr. 2021, 60, 4279–4293.
  49. Núñez-Acuña, G.; Détrée, C.; Gallardo-Escárate, C.; Gonçalves, A.T. Functional Diets Modulate lncRNA-Coding RNAs and Gene Interactions in the Intestine of Rainbow Trout Oncorhynchus Mykiss. Mar. Biotechnol. 2017, 19, 287–300.
  50. Zhang, Q.; Xiao, X.; Zheng, J.; Li, M.; Yu, M.; Ping, F.; Wang, T.; Wang, X. Improvement in Glucose Metabolism in Adult Male Offspring of Maternal Mice Fed Diets Supplemented with Inulin via Regulation of the Hepatic Long Noncoding RNA Profile. FASEB J. 2021, 35, e22003.
  51. Formichi, C.; Nigi, L.; Grieco, G.E.; Maccora, C.; Fignani, D.; Brusco, N.; Licata, G.; Sebastiani, G.; Dotta, F. Non-Coding Rnas: Novel Players in Insulin Resistance and Related Diseases. Int. J. Mol. Sci. 2021, 22, 7716.
  52. Chi, T.; Lin, J.; Wang, M.; Zhao, Y.; Liao, Z.; Wei, P. Non-Coding RNA as Biomarkers for Type 2 Diabetes Development and Clinical Management. Front. Endocrinol. 2021, 12, 1067.
  53. Perez, M.F.; Lehner, B. Intergenerational and Transgenerational Epigenetic Inheritance in Animals. Nat. Cell Biol. 2019, 21, 143–151.
  54. Gill-Randall, R.; Adams, D.; Ollerton, R.L.; Lewis, M.; Alcolado, J.C. Type 2 Diabetes Mellitus—Genes or Intrauterine Environment? An Embryo Transfer Paradigm in Rats. Diabetologia 2004, 47, 1354–1359.
  55. Dabelea, D.; Hanson, R.L.; Lindsay, R.S.; Pettitt, D.J.; Imperatore, G.; Gabir, M.M.; Roumain, J.; Bennett, P.H.; Knowler, W.C. Intrauterine Exposure to Diabetes Conveys Risks for Type 2 Diabetes and Obesity: A Study of Discordant Sibships. Diabetes 2000, 49, 2208–2211.
  56. Jimenez-Chillaron, J.C.; Isganaitis, E.; Charalambous, M.; Gesta, S.; Pentinat-Pelegrin, T.; Faucette, R.R.; Otis, J.P.; Chow, A.; Diaz, R.; Ferguson-Smith, A.; et al. Intergenerational Transmission of Glucose Intolerance and Obesity by in Utero Undernutrition in Mice. Diabetes 2009, 58, 460–468.
  57. Pavlinkova, G.; Margaryan, H.; Zatecka, E.; Valaskova, E.; Elzeinova, F.; Kubatova, A.; Bohuslavova, R.; Peknicova, J. Transgenerational Inheritance of Susceptibility to Diabetes-Induced Male Subfertility. Sci. Rep. 2017, 7, 4940.
  58. Sánchez-Soriano, C.; Pearson, E.R.; Reynolds, R.M. Associations between Parental Type 2 Diabetes Risk and Offspring Birthweight and Placental Weight: A Survival Analysis Using the Walker Cohort. Diabetologia 2022, 65, 2084–2097.
  59. Crudo, A.; Petropoulos, S.; Moisiadis, V.G.; Iqbal, M.; Kostaki, A.; Machnes, Z.; Szyf, M.; Matthews, S.G. Prenatal Synthetic Glucocorticoid Treatment Changes DNA Methylation States in Male Organ Systems: Multigenerational Effects. Endocrinology 2012, 153, 3269–3283.
  60. Painter, R.C.; Osmond, C.; Gluckman, P.; Hanson, M.; Phillips, D.I.; Roseboom, T.J. Transgenerational Effects of Prenatal Exposure to the Dutch Famine on Neonatal Adiposity and Health in Later Life. BJOG 2008, 115, 1243–1249.
  61. Barella, L.F.; de Oliveira, J.C.; Mathias, P.C. Pancreatic Islets and Their Roles in Metabolic Programming. Nutrition 2014, 30, 373–379.
  62. Bouret, S.; Levin, B.E.; Ozanne, S.E. Gene-Environment Interactions Controlling Energy and Glucose Homeostasis and the Developmental Origins of Obesity. Physiol. Rev. 2015, 95, 47–82.
  63. Nielsen, J.H.; Haase, T.N.; Jaksch, C.; Nalla, A.; Søstrup, B.; Nalla, A.A.; Larsen, L.; Rasmussen, M.; Dalgaard, L.T.; Gaarn, L.W.; et al. Impact of Fetal and Neonatal Environment on Beta Cell Function and Development of Diabetes. Acta Obs. Gynecol. Scand. 2014, 93, 1109–1122.
  64. Ockner, R.K.; Manning, J.A. Fatty Acid-Binding Protein in Small Intestine. Identification, Isolation, and Evidence for Its Role in Cellular Fatty Acid Transport. J. Clin. Investig. 1974, 54, 326–338.
More
Information
Contributors MDPI registered users' name will be linked to their SciProfiles pages. To register with us, please refer to https://encyclopedia.pub/register : , , , ,
View Times: 400
Revisions: 2 times (View History)
Update Date: 11 Jul 2023
1000/1000